Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations (2018)
- Authors:
- USP affiliated authors: HIRATA, ROSARIO DOMINGUEZ CRESPO - FCF ; HIRATA, MARIO HIROYUKI - FCF
- Unidade: FCF
- DOI: 10.1590/s2175-97902018000001005
- Subjects: DOENÇAS METABÓLICAS; POLIMORFISMO; FARMACOGENÉTICA
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Título do periódico: Brazilian Journal of Pharmaceutical Sciences
- ISSN: 1984-8250
- Volume/Número/Paginação/Ano: v. 54, special, p. 1-25 art. e01005, 2018
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
HIRATA, Rosario Dominguez Crespo et al. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, v. 54, p. 1-25 art. e01005, 2018Tradução . . Disponível em: https://doi.org/10.1590/s2175-97902018000001005. Acesso em: 14 maio 2024. -
APA
Hirata, R. D. C., Cerda, A., Genvigir, F. D. V., & Hirata, M. H. (2018). Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations. Brazilian Journal of Pharmaceutical Sciences, 54, 1-25 art. e01005. doi:10.1590/s2175-97902018000001005 -
NLM
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 maio 14 ] Available from: https://doi.org/10.1590/s2175-97902018000001005 -
Vancouver
Hirata RDC, Cerda A, Genvigir FDV, Hirata MH. Pharmacogenetic implications in the management of metabolic diseases in Brazilian populations [Internet]. Brazilian Journal of Pharmaceutical Sciences. 2018 ; 54 1-25 art. e01005.[citado 2024 maio 14 ] Available from: https://doi.org/10.1590/s2175-97902018000001005 - Could SNPs predict Cisplatin toxicity?
- Validation of TREML4 mRNA expression and polymorphisms in blood leukocytes as potential biomarker of atherosclerosis
- Bases farmacogenômicas da resistência medicamentosa
- Inclusion body formation in escherichia coli: a procedure for optimizing production of soluble protein in application to human interferon alpha receptor
- Expression of three polypeptide kfragments of human interferon alpha receptor cloning flexibility and optimization of expression efficienty
- Reconhecimento do receptor recombinante de ifn 'ALFA' / 'BETA' humano por anticorpos policlonais de coelho
- Human interferon alpha receptor: identification of the regeion involved in binding to interferon alpha b
- Cloning and expression of treponema pallidium 47 kda antigen in e. Coli dh5 'ALPHA'
- Estratégia de extração de DNA de manchas sanguíneas para testes forensicos por PCR
- Cloning of a fragment of the 5 noncoding region of HCV genome for using as an internal control in PCR
Informações sobre o DOI: 10.1590/s2175-97902018000001005 (Fonte: oaDOI API)
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas